agilon health (NYSE:AGL) Coverage Initiated at Needham & Company LLC

Equities researchers at Needham & Company LLC assumed coverage on shares of agilon health (NYSE:AGL) in a research note issued to investors on Friday,Briefing.com Automated Import reports. The firm set a “hold” rating on the stock.

Several other equities research analysts have also commented on AGL. Evercore ISI reduced their price objective on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Sanford C. Bernstein assumed coverage on agilon health in a research report on Wednesday, December 11th. They set a “market perform” rating and a $2.50 price objective on the stock. Stifel Nicolaus decreased their target price on shares of agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research note on Tuesday, November 12th. Finally, TD Cowen dropped their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health presently has a consensus rating of “Hold” and an average price target of $3.98.

agilon health Price Performance

AGL opened at $2.21 on Friday. agilon health has a 1 year low of $1.50 and a 1 year high of $9.30. The stock has a 50-day moving average price of $2.07 and a 200-day moving average price of $3.79. The firm has a market cap of $910.56 million, a PE ratio of -2.35 and a beta of 0.53. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the firm earned ($0.06) EPS. Sell-side analysts predict that agilon health will post -0.52 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In other agilon health news, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were purchased at an average cost of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. This represents a 27.93 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Karen Mcloughlin acquired 25,000 shares of the company’s stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, with a total value of $55,000.00. Following the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Arizona State Retirement System increased its holdings in agilon health by 2.5% during the 2nd quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock worth $562,000 after purchasing an additional 2,070 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health in the third quarter worth about $28,000. Wedbush Securities Inc. increased its position in agilon health by 72.6% during the 2nd quarter. Wedbush Securities Inc. now owns 20,710 shares of the company’s stock valued at $135,000 after purchasing an additional 8,710 shares during the period. AGF Management Ltd. raised its holdings in shares of agilon health by 3.3% in the 2nd quarter. AGF Management Ltd. now owns 381,915 shares of the company’s stock valued at $2,498,000 after purchasing an additional 12,063 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of agilon health by 42.4% in the 2nd quarter. Principal Financial Group Inc. now owns 41,675 shares of the company’s stock valued at $273,000 after purchasing an additional 12,411 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.